bioAffinity Technologies’ Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues
Go back to bioAffinity Technologies’ Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues| (NASDAQ: BIAF) | Delayed: 7.70 -1.73 (18.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.43 | 52 Week High | $ | |||
| Open | $8.39 | 52 Week Low | $ | |||
| Day High | $8.80 | P/E | N/A | |||
| Day Low | $7.37 | EPS | $ | |||
| Volume | 736,327 | |||||
| (NASDAQ: BIAFW) | Delayed: 0.29 -0.01 (3.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.30 | 52 Week High | $ | |||
| Open | $0.31 | 52 Week Low | $ | |||
| Day High | $0.31 | P/E | N/A | |||
| Day Low | $0.29 | EPS | $ | |||
| Volume | 2,624 | |||||
